Clinical Radiology
Volume 64, Issue 4 , Pages 403-413 , April 2009

Risk–benefit analysis of preoperative breast MRI in patients with primary breast cancer

  • K.C. Siegmann

      Affiliations

    • Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany
    • Corresponding Author InformationGuarantor and correspondent: K. Siegmann, Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany. Tel.: +49 7071 2982087; fax: +49 7071 295845.
  • ,
  • A. Baur

      Affiliations

    • Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany
  • ,
  • U. Vogel

      Affiliations

    • Institute of Pathology, University Hospital Tuebingen, Tuebingen, Germany
  • ,
  • B. Kraemer

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital Tuebingen, Tuebingen, Germany
  • ,
  • M. Hahn

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital Tuebingen, Tuebingen, Germany
  • ,
  • C.D. Claussen

      Affiliations

    • Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany

Received 24 July 2008 ,Revised 27 November 2008 ,Accepted 2 December 2008.

References 

  1. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773–778
  2. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180:333–341
  3. Viehweg P, Rotter K, Laniado M, et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol. 2004;14:402–408
  4. Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol. 2004;14:809–816
  5. Deurloo EE, Klein Zeggelink WFA, Teertstra HJ, et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol. 2006;16:692–701
  6. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–849
  7. Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901–910
  8. Libermann L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am. 2006;14:339–349
  9. Van Goethem M, Tjalma W, Schelfout K, et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol. 2006;32:901–910
  10. Ozaki S, Tozaki M, Fukuma E, et al. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer?. Breast Cancer. 2008;15:169–174
  11. Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725–1731
  12. Solin LJ, Orel SG, Hwang W-T, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ducal carcinoma in situ. J Clin Oncol. 2008;26:386–391
  13. Kuhl C, Kuhn W, Braun M, et al. Pre-operative staging of breast cancer with breast MRI: one step forward, two Steps back?. Breast. 2007;16(Suppl. 2):S34–S44
  14. Tillman GF, Orel SG, Schnall MD, et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20:3413–3423
  15. Kerlikowske K, Shepherd J, Creasman J, et al. Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst. 2005;97:368–374
  16. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165–175
  17. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149–1157
  18. Menell JH, Morris EA, Dershaw DD, et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11:382–390
  19. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–492
  20. Schelfout K, Van Goethem M, Kersschot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14:1209–1216
  21. Weinstein SP, Orel SG, Heller R, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol. 2001;176:399–406
  22. American College of Radiology (ACR) . Breast imaging reporting and data system® (BI-RADS®) atlas. 4th edn. Reston: American College of Radiology; 2003;
  23. Baum F, Fischer U, Vosshenrich R, et al. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol. 2002;12:1087–1092
  24. Ruthgers EJTh. Position Paper EUSOMA guidelines. Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 2001;37:447–453
  25. Siegmann KC, Gorriz C, Xydeas T, et al. Preoperative MR imaging-guided localization of 131 breast lesions with modified embolization coils. Invest Radiol. 2005;40:368–377
  26. Tavassoli FA, Devillee P. World Health Organization Classification of tumors. pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press; 2003;
  27. In:  Sobin LH,  Wittekind CH editor. UICC TNM classification of malignant tumours. 6th edn.. New York: Wiley-Liss; 2002;
  28. Mameri CS, Kemp C, Goldman SM, et al. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J. 2008;14:236–244
  29. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–473
  30. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735–2742

PII: S0009-9260(08)00492-3

doi: 10.1016/j.crad.2008.12.002

Clinical Radiology
Volume 64, Issue 4 , Pages 403-413 , April 2009